Liquid Biopsy Market

Request Customization

Liquid Biopsy Market Research Report – Segmentation By Biomarker Type (Circulating Tumor DNA, Circulating Tumor Cells, Exosomes and Extracellular Vesicles, Celll-Free DNA, RNA biomarkers, Others); By Application (Cancer Diagnosis, Prognosis and Monitoring, Therapy Selection, Recurrence Detection, Non-Cancer Applications); and Region - Size, Share, Growth Analysis | Forecast (2025– 2030)

Published: 2025 - Feb

Report Code: VMR-176

Region: Global

Historic Range: 2022-2024

Forecast: 2025-2031

Format: Excel and PDF

Chapter 1. Report Scope & Methodology

Market Segmentation

1.1 Scope, Assumptions & Limitations
1.2 Research Methodology
1.3 Primary Sources
1.4 Secondary Sources

Chapter 2. Executive Summary

Market Segmentation

2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis

📥 Download Sample Report

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

FAQ's

The Global Liquid Biopsy Market was valued at USD 9.63 billion in 2024 and is projected to reach a market size of USD 12.1 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 4.67%.

The global liquid biopsy market is driven by the rising demand for non-invasive, real-time cancer diagnostics. Technological advancements in genomic sequencing and personalised medicine are further accelerating market growth.

Based on Service Provider, the Global Liquid Biopsy Market is segmented into material manufacturers, Raw Material Suppliers, Lab information management systems, Distributors & Wholesalers, End-to-End Solution Providers.

North America is the most dominant region for the Global Liquid Biopsy Market.

Guardant Health, Bio-Rad Laboratories, QIAGEN, Roche, Illumina, Thermo Fisher Scientific, Exact Sciences, and Myriad Genetics are the key players in the Global Liquid Biopsy Market.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

4250

Multi User

5250

Corporate User

6900

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe